Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to assess the efficacy and safety of a combination of
aminobutyric acid, glutamic acid, calcium, thiamine, pyridoxine and cyanocobalamin as
adjuvant therapy for vertigo comparatively to ginger under a double-blind randomized study
design.
Phase:
Phase 4
Details
Lead Sponsor:
Fundação Educacional Serra dos Órgãos
Treatments:
gamma-Aminobutyric Acid Hydroxocobalamin Pyridoxine Thiamine Vitamin B 12